Your browser doesn't support javascript.
loading
Dermatologic adverse events in acute lymphocytic leukemia patients treated with bispecific T-cell engager blinatumomab.
Parisi, Rose; Cowen, Emily A; Gu, Stephanie; Dusza, Stephen; Pulitzer, Melissa; Geyer, Mark B; King, Amber C; Markova, Alina.
  • Parisi R; Department of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Cowen EA; Department of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Gu S; Department of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Dusza S; Department of Medicine, Dermatology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Pulitzer M; Department of Pathology and Laboratory Medicine, Dermatopathology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Geyer MB; Weill Cornell Medical College, Cornell University, New York, NY, USA.
  • King AC; Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Markova A; Department of Pharmacy, Clinical Services, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Leuk Lymphoma ; 64(9): 1583-1587, 2023 09.
Article en En | MEDLINE | ID: mdl-37309201

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Leucemia-Linfoma Linfoblástico de Células Precursoras B / Anticuerpos Biespecíficos / Leucemia-Linfoma Linfoblástico de Células Precursoras / Antineoplásicos Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma no Hodgkin / Leucemia-Linfoma Linfoblástico de Células Precursoras B / Anticuerpos Biespecíficos / Leucemia-Linfoma Linfoblástico de Células Precursoras / Antineoplásicos Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article